Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Many were ineligible or decided against taking the medications due to potential side effects and the high cost, a study has found.
Many were ineligible or decided against taking the medications due to potential side effects and the high cost, a study has found.
DayOff News Summary
This article is aggregated from Japan Times. DayOff News presents the headline and excerpt to help you discover global news. Click below to read the complete article on the original publisher's website.
Read Full Article at → Japan Times